This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Spectranetics Receives CE Mark For TightRail(TM) Rotating Dilator Sheath Platform

COLORADO SPRINGS, Colo., May 22, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced receipt of CE marking for the TightRail™ Rotating Dilator Sheath platform. The product combines unprecedented shaft flexibility and column strength to help physicians safely navigate the vasculature during cardiac lead extraction procedures. The announcement includes TightRail and a companion product: TightRail™ Mini Rotating Dilator Sheath. The Mini is designed to gain vascular access, dilating heavily fibrosed and calcified tissue. The new platform will be used to treat patients at facilities in Europe that are participating in Spectranetics' initial limited launch.

SightRail™ Manual Dilator Sheath, a partner platform, was awarded the CE mark in April and features visual indicators that show bevel orientation and tip alignment, supplementing fluoroscopy as a means to determine position and orientation These new platforms represent Spectranetics' entry into the mechanical extraction device market, complementing the laser-based technology that established the company's leading position in cardiac lead extraction.

On the heels of completing TightRail's first in-patient case with Dr. Charles Love, Spectranetics debuted TightRail at the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco earlier this month. Over 200 physicians participated in the "hands-on" Solutions Experience hosted by Spectranetics. TightRail will also headline the CardioStim conference in Nice, France, in June. Donna Ford-Serbu, Senior Vice President, Sales and Marketing for Spectranetics Lead Management business unit, sees the mechanical extraction devices as an exciting addition to the company's portfolio of lead extraction solutions. "By providing a wider range of clinical solutions, we are responding to a global need for innovative extraction options," said Ford-Serbu. "Physicians are always looking for ways to serve their patient's needs – we are committed to providing tools that extend life and ensure physicians are successful at every turn." There are over seven million implanted cardiac devices globally. Each year, about 750,000 additional patients are implanted with these devices worldwide, translating to 1.5 million leads. It is estimated that in 2014, roughly 400,000 patients will meet indications for a lead extraction procedure.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs